First Tracks Biotherapeutics, Inc. SEC filings TRAX

First Tracks Biotherapeutics, Inc. has 98 filings in SEC EDGAR's recent list, going back to Feb 6, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Results of operations
 Nov 3, 2026 Nov 3, 2026
8-K Current report
Material agreement
 Oct 20, 2026 Oct 19, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
 Oct 15, 2026 Oct 15, 2026
8-K Current report
Regulation FD disclosure, Other events
 Oct 13, 2026 Oct 12, 2026
8-K Current report
Results of operations
 Aug 12, 2026 Aug 12, 2026
8-K Current report
Material agreement
 Jun 22, 2026 Jun 15, 2026
8-K Current report
Results of operations
 May 14, 2026 May 14, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
 Apr 20, 2026 Apr 20, 2026
8-K Current report
Regulation FD disclosure
 Apr 3, 2026 Apr 1, 2026

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TRAX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2091349
Former names
Biopharma Company, Inc. (until Feb 6, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.